The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Cephalosporin Global Market Report 2024, the cephalosporin market is expected to show significant growth in the forecast period.

The cephalosporin market has shown consistent growth in recent years, driven by various factors such as the increasing prevalence of bacterial infections, antibiotic resistance, and the rising number of surgical procedures. This blog delves into the factors contributing to this growth, the forecast for the coming years, and key industry trends.

Current Market Size and Growth

• Market Size 2023: $17.04 billion
• Expected Market Size 2024: $17.69 billion
• CAGR (2023-2024): 3.8%

The cephalosporin market has experienced steady growth due to several critical factors:

• Growing Prevalence of Bacterial Infections: Increasing incidences of infections that require antibiotic treatment.
• Antibiotic Resistance: Rising antibiotic resistance necessitates the development of more effective cephalosporin antibiotics.
• Surgical Procedures and Hospitalizations: More surgeries and hospital stays increase the demand for antibiotics to prevent and treat infections.
• Awareness and Regulatory Support: Increased awareness among healthcare professionals and supportive regulations for antibiotic development boost market growth.

Forecast for the Cephalosporin Market

• Market Size 2028: $20.29 billion
• CAGR (2024-2028): 3.5%

View More On The Cephalosporin Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cephalosporin-global-market-report

The forecasted growth is attributed to:

• Global Burden of Infectious Diseases: A continued increase in infectious diseases worldwide.
• Bacterial Resistance: Ongoing challenges with emerging bacterial resistance.
• Surgical Interventions: Continued growth in surgical procedures and healthcare-associated infections.
• Broad-Spectrum Antibiotics Demand: Increased need for antibiotics effective against a wide range of bacteria.
• Reimbursement Policies: Evolving reimbursement policies influencing market dynamics.

Key Market Trends

Technological Advancements and New Therapies

• Advanced-Generation Cephalosporins: Companies are focusing on developing advanced-generation cephalosporins to tackle antibiotic resistance.
• Ceftobiprole: A broad-spectrum cephalosporin used for treating various infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
  • Example: In July 2022, Mast Group Ltd. launched Ceftobiprole 5µg for antimicrobial susceptibility testing.

Strategic Acquisitions

• Sandoz International’s Acquisition: In October 2021, Sandoz International GmbH acquired GlaxoSmithKline PLC’s cephalosporin antibiotic business.
  • Impact: The acquisition included established brands like Zinnat, Zinacef, and Fortum, enhancing Sandoz’s antibiotic portfolio.

Factors Driving Market Growth

Rising Prevalence of Infectious Diseases

• Infectious Diseases: Illnesses caused by bacteria, viruses, fungi, and parasites.
• Impact: Increased prevalence drives demand for cephalosporin antibiotics.
  • Example: According to the CDC, TB cases in the US rose from 7,874 in 2021 to 8,300 in 2022.

Advanced-Generation Therapies

• Development of New Products: Companies are enhancing their portfolios with effective therapies against a broader spectrum of infections.
• Key Product: Ceftobiprole, a 5th-generation cephalosporin, is effective against MRSA and used for pneumonia treatment.

Market Segmentation

The cephalosporin market is segmented by:

1. Type: Branded, Generic
2. Route of Administration: Injection, Oral
3. Application: Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, Sexually Transmitted Infection, Other Applications

Regional Insights

• Asia-Pacific: The largest region in the cephalosporin market in 2023.

Conclusion

The cephalosporin market continues to grow steadily, driven by the rising prevalence of infectious diseases, antibiotic resistance, and technological advancements. With strategic acquisitions and the development of advanced-generation therapies, the market is well-positioned for continued growth in the coming years.

Request A Sample Of The Global Cephalosporin Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13402&type=smp